MIRA Pharmaceuticals, Price To Book vs. Short Ratio
| MIRA Stock | 1.27 0.01 0.78% |
For MIRA Pharmaceuticals, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MIRA Pharmaceuticals, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MIRA Pharmaceuticals, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MIRA Pharmaceuticals,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MIRA Pharmaceuticals, Common over time as well as its relative position and ranking within its peers.
MIRA |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MIRA Pharmaceuticals, Short Ratio vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MIRA Pharmaceuticals,'s current stock value. Our valuation model uses many indicators to compare MIRA Pharmaceuticals, value to that of its competitors to determine the firm's financial worth. MIRA Pharmaceuticals, Common is considered to be number one stock in price to book category among its peers. It is regarded second in short ratio category among its peers fabricating about 0.08 of Short Ratio per Price To Book. The ratio of Price To Book to Short Ratio for MIRA Pharmaceuticals, Common is roughly 12.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MIRA Pharmaceuticals,'s earnings, one of the primary drivers of an investment's value.MIRA Short Ratio vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
MIRA Pharmaceuticals, |
| = | 5.89 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
MIRA Pharmaceuticals, |
| = | 0.47 X |
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
MIRA Short Ratio Comparison
MIRA Pharmaceuticals, is currently under evaluation in short ratio category among its peers.
MIRA Pharmaceuticals, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MIRA Pharmaceuticals,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MIRA Pharmaceuticals, will eventually generate negative long term returns. The profitability progress is the general direction of MIRA Pharmaceuticals,'s change in net profit over the period of time. It can combine multiple indicators of MIRA Pharmaceuticals,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5.3 K | -5.6 K | |
| Operating Income | -8.5 M | -8.1 M | |
| Income Before Tax | -12 M | -11.4 M | |
| Total Other Income Expense Net | -3.5 M | -3.3 M | |
| Net Loss | -6.4 M | -6 M | |
| Net Loss | -12 K | -12.6 K | |
| Income Tax Expense | -8.5 K | -8.1 K | |
| Net Interest Income | -727 K | -690.7 K | |
| Net Loss | -7.5 M | -7.9 M | |
| Change To Netincome | 1.5 M | 1.6 M | |
| Net Loss | (0.65) | (0.68) | |
| Income Quality | 0.38 | 0.66 |
MIRA Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MIRA Pharmaceuticals,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MIRA Pharmaceuticals, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MIRA Pharmaceuticals,'s important profitability drivers and their relationship over time.
Use MIRA Pharmaceuticals, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MIRA Pharmaceuticals, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MIRA Pharmaceuticals, will appreciate offsetting losses from the drop in the long position's value.MIRA Pharmaceuticals, Pair Trading
MIRA Pharmaceuticals, Common Pair Trading Analysis
The ability to find closely correlated positions to MIRA Pharmaceuticals, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MIRA Pharmaceuticals, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MIRA Pharmaceuticals, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MIRA Pharmaceuticals, Common to buy it.
The correlation of MIRA Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MIRA Pharmaceuticals, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MIRA Pharmaceuticals, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MIRA Pharmaceuticals, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MIRA Pharmaceuticals, position
In addition to having MIRA Pharmaceuticals, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Dividend Beast Thematic Idea Now
Dividend Beast
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
To fully project MIRA Pharmaceuticals,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MIRA Pharmaceuticals, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MIRA Pharmaceuticals,'s income statement, its balance sheet, and the statement of cash flows.